Epidemiology: Goutbad for the heart as well as the joint

Nature Reviews Rheumatology

Volumn 6, Issue 7, 2010, Pages 386-387

  So, Alexander ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; GENETIC VARIABILITY; GOUT; HUMAN; HYPERTENSION; HYPERURICEMIA; INFLAMMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; CANADA; HEART INFARCTION; NOTE;

BRITISH COLUMBIA; GOUT; HUMANS; MYOCARDIAL INFARCTION;

EID: 77954289997     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.78     Document Type: Short Survey

References (9)

1. Gertler, M. M., Garn, S. M. & Levine, S. A. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann. Intern. Med. 34, 1421-1431 (1951).
2. De Vera, M., Rahman, A., Bhole, V., Kopec, J. A. & Choi, H. K. Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann. Rheum. Dis. doi:10.1136/ard.2009. 122770.
3. Harrold, L. R., et al. Validity of gout diagnoses in administrative data. Arthritis Rheum. 57, 103-108 (2007).
4. Kim, S. Y., et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res. (Hoboken) 62, 170-180 (2010).
5. Kanellis, J. & Kang, D. H. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin. Nephrol. 25, 39-42 (2005).
6. Sánchez-Lozada, L. G., et al. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am. J. Physiol. Renal Physiol. 295, F1134-F1141 (2008).
7. So, A. Developments in the scientific and clinical understanding of gout. Arthritis Res. Ther. 10, 221 (2008).
8. Kolz, M., et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 5, e1000504 (2009).
9. Vitart, V., et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat. Genet. 40, 437-442 (2008).